COMP <GO>
CHWY vs PG // EV/EBITDA & P/E VALUATION
Chewy Inc. (NYSE) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: CHWY 4
— PG 11
▲ EV/EBITDA & P/E VALUATION LEADER: CHWY
LAST: $21.29 (+2.21%) • MKT CAP: $8.37B
valuation
10.2x
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
valuation
16.2x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CHWY VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CHWY | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 29.80% | 51.20% | -21.40 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 30.00% | 25.40% | +4.60 | CHWY | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 10.2x | 16.2x | -6.00 | CHWY | /valuation <GO> |
| Free Cash Flow Yield | 1.49% | 3.77% | -2.28 | PG | /fcf-yield <GO> |
| Operating Margin | 2.00% | 24.30% | -22.30 | PG | /operating-margins <GO> |
| Net Profit Margin | 1.80% | 19.00% | -17.20 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 6.20% | 0.30% | +5.90 | CHWY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.08 | 5.59 | -0.51 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.50% | +0.10 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.1 | 62.7 | -7.62 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.91 | 0.87 | +0.04 | CHWY | /macro-sensitivity <GO> |
| Forward P/E Multiple | 35.0x | 21.7x | +13.30 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $8.37B | $372.21B | -$363.84B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CHWY REV | PG REV | CHWY GROSS % | PG GROSS % | CHWY FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $12.60B | $84.28B | 29.8% | 51.2% | $124.5M | $14.04B |
| FY 2024 | $11.86B | $84.04B | 29.2% | 51.4% | $62.5M | $16.52B |
| FY 2023 | $11.15B | $82.01B | 44.0% | 44.0% | -$15.4M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CHWY // BETA 0.91
PG // BETA 0.87